Privia Health Group, Inc. ( (PRVA) ) has released its Q3 earnings. Here is a breakdown of the information Privia Health Group, Inc. presented to its investors.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Privia Health Group, Inc. is a leading physician enablement company in the United States, operating in the healthcare sector with a focus on building provider networks and offering technology and service solutions to optimize medical practices.
Privia Health has reported a robust financial performance for the third quarter of 2025, with significant increases in net income and adjusted EBITDA compared to the previous year. The company has also raised its full-year guidance, reflecting strong operational and financial metrics.
Key highlights from the earnings report include a 32.5% increase in total revenue, a 147.8% rise in operating income, and a 94.1% increase in net income compared to the third quarter of 2024. The company also reported a 27.1% increase in practice collections and a 61.6% rise in adjusted EBITDA. Additionally, Privia Health announced a strategic acquisition of an ACO business from Evolent Health, which is expected to expand its value-based care footprint.
The company has maintained a strong balance sheet with $441.4 million in cash and no debt, positioning it well for future growth. The acquisition of the ACO business is anticipated to close in the fourth quarter of 2025 and is expected to positively impact adjusted EBITDA in 2026.
Looking ahead, Privia Health’s management remains optimistic about the company’s growth prospects, supported by its strategic initiatives and strong financial position. The raised guidance for 2025 reflects confidence in continued operational excellence and market expansion.